Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

AUTOMATED PROTOTYPE OF CANCER DETECTION FROM CTDNA

Objective

Floating Genes is a French deeptech startup incorporated in October 2021, developing early cancer detection tools from liquid biopsies. The company focuses on digestive cancers, and especially colorectal and pancreatic cancer, which is mostly detected in stage 4 and show 4.3 month of median survival. Floating Genes has developed and patented molecular biology tools to detect very rare circulating tumor DNA (ctDNA) in the blood. This will eventually allow earlier cancer diagnosis, precise monitoring and personalized treatment of patients with cancer. 200,000 lives could be saved every year in Europe with such an earlier diagnosis tool.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIE-2022-SCALEUP-02

See all projects funded under this call

Coordinator

FLOATING GENES
Net EU contribution
€ 75 000,00
Address
4 RUE PIERRE FONTAINE
91058 Evry-Courcouronnes
France
SME
Yes
Region
Ile-de-France Ile-de-France Essonne
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data